Schumacher, Martin, 1950-
Schumacher, Martin
Schumacher, M. Martin
Schumacher, Martin, medicijnen
Martin Schumacher Statistiker
VIAF ID: 168778891 ( Personal )
Permalink: http://viaf.org/viaf/168778891
Preferred Forms
- 100 0 _ ‡a Martin Schumacher ‡c Statistiker
-
-
- 100 1 _ ‡a Schumacher, Martin
-
-
- 100 1 _ ‡a Schumacher, Martin ‡d 1950-
- 100 1 _ ‡a Schumacher, Martin ‡d 1950-
-
- 100 1 _ ‡a Schumacher, Martin, ‡d 1950-
- 100 1 _ ‡a Schumacher, Martin, ‡d 1950-
-
4xx's: Alternate Name Forms (6)
5xx's: Related Names (7)
- 510 2 _ ‡a Albert-Ludwigs-Universität Freiburg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Dortmund ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Universität Dortmund ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universität Heidelberg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universität Dortmund
- 510 2 _ ‡a Universität Freiburg im Breisgau
- 510 2 _ ‡a Workshop on Statistical Methods for Incomplete Covariate Data in Clinical and Epidemiological Studies (16-02-1995 - 18-02-1995 : Freiburg, Germany)
Works
Title | Sources |
---|---|
Analyse von Überlebenszeiten bei nichtproportionalen Hazardfunktionen | |
Analyzing the impact of duration of ventilation, hospitalization, and ventilation episodes on the risk of pneumonia | |
Approximation von entarteten linearen Modellen durch Modelle mit vollem Rang | |
Auswertung zweier Studien, mit dem Ziel zu überprüfen ob, bedingt durch Luftemissionen, eine Zunahme der mutagenen Stoffe im Urin von Personen nachgewiesen werden kann Praktikumsbericht | |
Basic parametric analysis for a multi-state model in hospital epidemiology | |
Bias due to censoring of deaths when calculating extra length of stay for patients acquiring a hospital infection | |
Bioassay | |
Clinical trials for personalized, marker-based treatment strategies | |
Comparison of complex modeling strategies for prediction of a binary outcome based on a few, highly correlated predictors | |
Competing risks and multistate models with R, c2012: | |
Compression-decompression of multivariate data via maximum entropy resampling and applications to inference | |
Control procedures and estimators of the false discovery rate and their application in low-dimensional settings: an empirical investigation | |
Doug Altman: driving critical appraisal and improvements in the quality of methodological and medical research | |
Estimands to quantify prolonged hospital stay associated with nosocomial infections | |
General survival time models for analysing drug combination treatments | |
Identifying prognostic SNPs in clinical cohorts: complementing univariate analyses by resampling and multivariable modeling | |
Improving the prognostic ability through better use of standard clinical data - the Nottingham prognostic index as an example | |
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT) | |
Maximally selected rank statistics | |
Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA‐REG OUTCOME trial | |
Methodik klinischer Studien methodische Grundlagen der Planung, Durchführung und Auswertung | |
Methods for evaluating medical tests and biomarkers | |
Missing disease information due to death in time-to-event analyses of cohort studies = Fehlende Erkrankungsinformation aufgrund von Tod in Ereigniszeitanalysen von Kohortenstudien | |
Modelkomplexitätswahl in der Ereigniszeitanalyse hochdimensionaler Daten | |
Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies | |
Multi-state models for analyzing the publication process of clinical studies | |
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures | |
Multistate models for analysing adverse events in the presence of left-truncation = Mehrstadien-Modelle um die Analyse unerwünschter Ereignisse mit linkstrunkierten Daten | |
A multivariable approach for risk markers from pooled molecular data with only partial overlap | |
Multivariable modeling of continuous covariates with a spike at zero | |
Netboost: boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and huntington's disease | |
Netboost: statistical modeling strategies for high-dimensional data | |
Neuraminidase inhibitors and hospital mortality in british patients with H1N1 influenza A: a re-analysis of observational data | |
nonparametric approach to the statistical analysis of mutagenicity data | |
Nosokomiale Infektionen in Deutschland Erfassung und Prävention ; (NIDEP-Studie) | |
On pseudo-values for regression analysis in competing risks models | |
On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology | |
On the relation between the cause‐specific hazard and the subdistribution rate for competing risks data: the Fine–Gray model revisited | |
Penalized logistic regression with low prevalence exposures beyond high dimensional settings | |
Penalized regression methods with sparse variables for modeling binary outcomes | |
population-attributable fraction for time-dependent exposures and competing risks | |
Quantifying and communicating the burden of COVID-19 | |
Rank tests and ties some properties of a rank test for complete block designs | |
Recovery of original individual person data (IPD) inferences from empirical IPD summaries only: applications to distributed computing under disclosure constraints | |
Regularized regression when covariates are linked on a network: the 3CoSE algorithm | |
relationship between quality of research and citation frequency | |
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients | |
Schätzmethoden in der Dosis-Wirkungs-Analyse | |
Sequential analysis of survival times in clinical trials | |
Simpson's paradox visualized: the example of the Rosiglitazone meta-analysis | |
Speaking in Gestures: left dorsal and ventral frontotemporal brain‐systems underlie communication in conducting | |
Statistical models for multivariate longitudinal data with application to the development of side effects during radiation therapy | |
Statistische Analyse von Experimenten in der biomedizinischen Forschung | |
Statistische Modellbildungsstrategien zur Verknüpfung multipler molekularer Quellen unter Berücksichtigung von Time-to-Event Endpunkten | |
Statistische Modelle für Effekte von zeitabhängigen Einflussgrößen bei Existenz von zeitabhängigen Konfoundern | |
Statistische Modellierung zur Risikobeurteilung in der Pharmakoepidemiologie: die case-crossover-Methode | |
time-dependent "cure-death" model investigating several endpoints simultaneously in trials treating high-risk patients with severe infections | |
Two-sample tests of Crámer- von Mises and Kolmogorov-Smirnov type for randomly censored data | |
Über asymptotische Potenzreihen in zwei Veränderlichen und ein zweidimensionales Momentenproblem | |
Undue reliance on I2 in assessing heterogeneity may mislead | |
Which patients to sample in clinical cohort studies when the number of events is high and measurement of additional markers is constrained by limited resources | |
Workshop on Statistical Methods for Incomplete Covariate Data in Clinical and Epidemiological S[t]udies |